11/10/2018 13:30:00

CVR Refining to Release Third Quarter 2018 Earnings

Related content
04 Oct - 
New Research Coverage Highlights Apogee Enterprises, Na..
17 Sep - 
CVR Refining Announces Intent to Sell Cushing Tank Farm..
25 Jul - 
CVR Refining Reports 2018 Second Quarter Results And An..

SUGAR LAND, Texas, Oct. 11, 2018 (GLOBE NEWSWIRE) -- CVR Refining, LP (NYSE: CVRR), a refiner and marketer of petroleum fuels, plans to release its third quarter 2018 results on Wednesday, Oct. 24, after the close of trading on the New York Stock Exchange. The company will host a teleconference call on Oct. 25 at 1 p.m. Eastern to discuss these results. 

This call, which will contain forward-looking information, will be webcast live and can be accessed on the Investor Relations section of CVR Refining’s website at www.CVRRefining.com. For investors or analysts who want to participate during the call, the dial-in number is (877) 407-8289. The webcast will be archived and available for 14 days at https://edge.media-server.com/m6/p/6g5xcnpz. A repeat of the call can be accessed through Nov. 8 by dialing (877) 660-6853, conference ID 13683848.

CVR Refining’s third quarter 2018 earnings news release will be distributed via GlobeNewswire and posted at www.CVRRefining.com.

About CVR Refining, LP

Headquartered in Sugar Land, Texas, CVR Refining, LP is an independent downstream energy limited partnership that owns refining and related logistics assets in the Midcontinent United States. CVR Refining’s subsidiaries operate a complex full coking medium-sour crude oil refinery with a capacity of 132,000 barrels per calendar day (bpcd) in Coffeyville, Kansas, and a complex crude oil refinery with a capacity of 74,500 bpcd in Wynnewood, Oklahoma. CVR Refining’s subsidiaries also operate and invest in supporting logistics assets, including approximately 570 miles of owned, leased and joint venture pipelines, approximately 130 crude oil transports, a network of strategically located crude oil gathering tank farms, and approximately 6.4 million barrels of owned and leased crude oil storage capacity.

For further information, please contact:

Investor Contact:

Jay Finks

CVR Refining, LP

(281) 207-3588

IR@CVRRefining.com

Media Relations:

Brandee Stephens

CVR Refining, LP

(281) 207-3516

MediaRelations@CVRRefining.com

CVRR-logo-4c.png

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg

HSBC Bank Plc : Form 8.5 (EPT/RI) - Lonmin PLC

22/02/2018 10:54:53
FORM 8.5 EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Name of exempt principal trader: HSBC BANK PLC (b) Name of offeror/offeree i..

Rathbone Brothers Plc : Preliminary announcement of 2017 results

22/02/2018 07:00:19
Funds under management up 14.3% to £39.1 billionThis is a preliminary statement of annual results published in accordance with FCA Listing Rule 9.7A. It covers the year ended 31 December 2017. Mark Nicholls, Chairman of Rathbone Brothers Plc, said: "UK and global investment markets performed well in 2017, with some indices reaching record levels towards the end of the year. This outcome has b..

Elliott Capital Advisors, L.P : Form 8.3 - GKN Plc

Related news
21/02/2018 15:25:10
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the "Code") 1.         KEY INFORMATION (a) Full name of discloser: Elliott Capital Advisors, L.P. (for itself and related general partners ..

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
MERGER ALERT – SNMX and IMPV: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
2
Larson Electronics Releases Explosion Proof Extension Cord with Three 16-Amp 600V Receptacles
3
EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ™ (fluocinolone acetonide intravitreal implant) 0.18 mg
4
MERGER ALERT – NAVG, ESL and ANCX: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
5
Roche launches NGS AVENIO Tumor Tissue Analysis Kits for oncology research

Related stock quotes

Buy and sell signals

  • Trend
  • Moneymachine

Copyright Berlingske Media 2018  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
15 October 2018 16:39:46
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20181005.3 - EUROWEB4 - 2018-10-15 17:39:46 - 2018-10-15 16:39:46 - 1000 - Website: OKAY